Hippocampal atrophy predicts conversion to dementia after STN-DBS in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 15, Issue 7, 2009, Pages 521-524

  Aybek, Selma ^a   Lazeyras, Francois ^b   Gronchi Perrin, Aline ^a   Burkhard, Pierre R ^c   Villemure, Jean Guy ^a   Vingerhoets, Francois J G ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Deep brain stimulation; Hippocampus; Parkinson's disease dementia; Volumetric MRI

Indexed keywords

AGED; ARTICLE; BRAIN ATROPHY; BRAIN DEPTH STIMULATION; BRAIN SIZE; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HIPPOCAMPUS ATROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SCORING SYSTEM;

AGED; ATROPHY; CASE-CONTROL STUDIES; COHORT STUDIES; DEEP BRAIN STIMULATION; DEMENTIA; FEMALE; HIPPOCAMPUS; HUMANS; IMAGING, THREE-DIMENSIONAL; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX;

EID: 67650735435     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2009.01.003     Document Type: Article

References (29)

1. Aarsland D., Andersen K., Larsen J.P., Lolk A., Nielsen H., and Kragh-Sorensen P. Risk of dementia in Parkinson's disease: a community-based, prospective study. Neurology 56 6 (2001) 730-736
2. Aarsland D., Larsen J.P., Tandberg E., and Laake K. Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. J Am Geriatr Soc 48 8 (2000) 938-942
3. Ardouin C., Pillon B., Peiffer E., Bejjani P., Limousin P., Damier P., et al. Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol 46 2 (1999) 217-223
4. Krack P., Batir A., Van Blercom N., Chanardes S., Fraix V., Ardouin C., et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 349 20 (2003) 1925-1934
5. Aybek S., Gronchi-Perrin A., Berney A., Chiuve S., Villemure J.G., Burhard P., et al. Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson's disease. Mov Disord 22 7 (2007) 974-981
6. Laakso M.P., Partanen K., Riekkinen P., Lehtovirta M., Hallikainen M., Hanninen T., et al. Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: an MRI study. Neurology 46 3 (1996) 678-681
7. Junque C., Ramirez-Ruiz B., Tolosa E., Summerfield C., Marti M., Pastor P., et al. Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia. Mov Disord 20 5 (2005) 540-544
8. Csernansky J.G., Wang L., Swank J., Miller J.P., Gado M., McKeel D., et al. Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly. Neuroimage 25 3 (2005) 783-792
9. Korf E.S., Wahlund L.O., Visser P.J., and Scheltens P. Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology 63 1 (2004) 94-100
10. deToledo-Morrell L., Stoub T.R., Bulgakova M., Wilson R., Benett D.A., Leurgans S., et al. MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD. Neurobiol Aging 25 9 (2004) 1197-1203
11. Tam C.W., Burton E.J., McKeith I.G., and Burn D.J. O'Brien JT. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies. Neurology 64 5 (2005) 861-865
12. Vingerhoets F.J., Villemure J.G., Temperli P., Pollo C., Pralong E., and Ghika J. Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up. Neurology 58 3 (2002) 396-401
13. Aarsland D., Andersen K., Larsen J.P., Perry R., Wentzel-Larsen T., Lolk A., et al. The rate of cognitive decline in Parkinson disease. Arch Neurol 61 12 (2004) 1906-1911
14. Pollo C., Meuli R., Maeder P., Vingerhoets F., Ghika J., and Villemure J.G. Subthalamic nucleus deep brain stimulation for Parkinson's disease: magnetic resonance imaging targeting using visible anatomical landmarks. Stereotact Funct Neurosurg 80 1-4 (2003) 76-81
15. Watson C., Andermann F., Gloor P., Jones-Gotman M., Peters T., Evans A., et al. Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging. Neurology 42 9 (1992) 1743-1750
16. Prastawa M., Gilmore J.H., Lin W., and Gerig G. Automatic segmentation of MR images of the developing newborn brain. Med Image Anal 9 5 (2005) 457-466
17. Camicioli R., Moore M.M., Kinney A., Corbridge E., Glassberg K., and Kaye J.A. Parkinson's disease is associated with hippocampal atrophy. Mov Disord 18 7 (2003) 784-790
18. Visser P.J., Verhey F.R., Hofman P.A., Scheltens P., and Jolles J. Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry 72 4 (2002) 491-497
19. Apaydin H., Ahlskog J.E., Parisi J.E., Boeve B.F., and Dickson D.W. Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Arch Neurol 59 1 (2002) 102-112
20. Papapetropoulos S., Lieberman A., Gonzalez J., and Mash D.C. Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease?. Acta Neurol Scand 111 6 (2005) 353-359
21. Braak H., Rub U., Jansen Steur E.N., Del Tredici K., and de Vos R.A. Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 64 8 (2005) 1404-1410
22. Saint-Cyr J.A., Trepanier L.L., Kumar R., Lozano A.M., and Lang A.E. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain 123 Pt 10 (2000) 2091-2108
23. Smeding H.M., Speelman J.D., Koning-Haanstra M., Schuurman P.R., Nijssen P., Van Laar T., et al. Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study. Neurology 66 12 (2006) 1830-1836
24. Schupbach W.M., Chastan N., Welter M.L., Houeto J.L., Mesnage V., Bonnet A.M., et al. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry 76 12 (2005) 1640-1644
25. Funkiewiez A., Ardouin C., Caputo E., Krack P., Fraix V., Klinger H., et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J Neurol Neurosurg Psychiatry 75 6 (2004) 834-839
26. Rodriguez-Oroz M.C., Zamarbide I., Guridi J., Palmero M.R., and Obeso J.A. Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease 4 years after surgery: double blind and open label evaluation. J Neurol Neurosurg Psychiatry 75 10 (2004) 1382-1385
27. Hobson P., and Meara J. Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom. Mov Disord 19 9 (2004) 1043-1049
28. Wider C., Pollo C., Bloch J., Burkhard P., and Vingerhoets F. Long-term outcome of 50 consecutive Parkinson's disease patients treated with subthalamic deep-brain stimulation. Parkinsonism Relat Disord 14 2 (2008 Mar) 114-119
29. Russmann H., Ghika J., Villemure J.G., Robert B., Bogousslavsky J., Burhard P., et al. Subthalamic nucleus deep brain stimulation in Parkinson disease patients over age 70 years. Neurology 63 10 (2004) 1952-1954